AI Article Synopsis
Article Abstract
Prion diseases are invariably fatal infectious diseases of the central nervous system. The prion protein has been identified as the underlying causative agent as PrP knockout mice (prnp(0/0)) are resistant to infection. This suggests that a significant reduction in the expression levels of PrP(c) should interrupt disease progression. Accomplishing this in vivo, upon presentation of symptoms, requires a mechanism that significantly reduces prnp mRNA levels while lacking potential side effects that may be cytotoxic or lethal to the host. Hybrid hammerhead ribozymes (HyHamRzs) include both a helicase recruitment signal and a tRNA(Val) promoter. HyHamRzs offer a means of highly specific and significant mRNA cleavage. In this study, data demonstrate increased activity granted to HamRzs by the addition of the helicase recruitment signal. Results show that three different HyHamRzs, targeting different locations along the full length prnp mRNA, reduced expression levels by greater than 95% relative to the control. It is postulated that HyHamRzs, modified to enhance serum stability and delivered intravenously to neurons by forming a complex with the modified rabies virus G protein (RVG), may offer a potential gene therapy strategy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/15287390903084314 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Exploring the genetic variability of the PRNP gene at codons 127, 142, 146, 154, 211, 222, and 240 in goats farmed in the Lombardy Region, Italy.
Vet Res
August 2024
Department of Veterinary Medicine and Animal Science, Università degli Studi di Milano, Via dell'Università 6, 26900, Lodi, Italy.
Article Synopsis
- Scrapie is a brain disease affecting sheep and goats, linked to the prion protein gene (PRNP), which determines animals' susceptibility to the disease.
- At a European level, disease surveillance is critical, with specific gene variations (K222, D/S146) identified as potential resistance factors for controlling scrapie.
- In a study of 956 goats in Italy's Lombardy region, researchers found genetic variations within the PRNP gene that could influence susceptibility to scrapie, discovering ten distinct haplotypes and highlighting the need for genetic management in disease prevention.
Modulation of prion protein expression through cryptic splice site manipulation.
J Biol Chem
August 2024
McCance Center for Brain Health and Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA. Electronic address:
Lowering expression of prion protein (PrP) is a well-validated therapeutic strategy in prion disease, but additional modalities are urgently needed. In other diseases, small molecules have proven capable of modulating pre-mRNA splicing, sometimes by forcing inclusion of cryptic exons that reduce gene expression. Here, we characterize a cryptic exon located in human PRNP's sole intron and evaluate its potential to reduce PrP expression through incorporation into the 5' untranslated region.
View Article and Find Full Text PDFDifferential expression of cellular prion protein (PrP) in mouse hepatitis virus induced neuroinflammation.
J Neurovirol
June 2024
Department of Biological Sciences, Indian Institute of Science Education and Research, Kolkata, Mohanpur, 741246, India.
The cellular prion protein (PrP) is an extracellular cell membrane protein. Due to its diversified roles, a definite role of PrP has been difficult to establish. During viral infection, PrP has been reported to play a pleiotropic role.
View Article and Find Full Text PDFmiR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages.
Biochim Biophys Acta Mol Basis Dis
June 2024
Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia, Barcelona, Spain; Department of Cell Biology, Physiology and Immunology, University of Barcelona, Barcelona, Spain; Institute of Neuroscience, University of Barcelona, Barcelona, Spain; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Madrid, Spain. Electronic address:
Clinical relevance of miRNAs as biomarkers is growing due to their stability and detection in biofluids. In this, diagnosis at asymptomatic stages of Alzheimer's disease (AD) remains a challenge since it can only be made at autopsy according to Braak NFT staging. Achieving the objective of detecting AD at early stages would allow possible therapies to be addressed before the onset of cognitive impairment.
View Article and Find Full Text PDFA Potential biomarker for the early diagnosis of OSCC: saliva and serum PrP.
J Cancer
January 2024
Precision Clinical Laboratory, Central People's Hospital of Zhanjiang, Zhanjiang, 524037 Guangdong, China.
Article Synopsis
- Oral squamous cell carcinoma (OSCC) is often diagnosed late, contributing to high mortality rates; this study focuses on the role of cellular prion protein (PrP) as a potential diagnostic biomarker.
- Researchers analyzed PrP levels in saliva and serum from OSCC patients, oral potentially malignant disorders (OPMD), and healthy controls, finding significantly higher levels in OSCC cases.
- The findings suggest that PrP correlates with tumor differentiation and stage, with promising diagnostic values (AUCs of 0.807 for saliva and 0.671 for serum), indicating its potential as an early diagnosis marker for OSCC.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!